Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Other Working Capital Changes (2024 - 2025)

Beta Bionics (BBNX) has disclosed Other Working Capital Changes for 2 consecutive years, with $6.7 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes rose 107.67% to $6.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.9 million through Dec 2025, up 221.49% year-over-year, with the annual reading at $15396.0 for FY2025, 64.54% down from the prior year.
  • Other Working Capital Changes hit $6.7 million in Q4 2025 for Beta Bionics, up from $15396.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $6.7 million in Q4 2025 to a low of -$1.7 million in Q3 2024.